NCT05176600

Brief Summary

The purpose of the study is to test the technical functionality, safety, and feasibility of a bimanual robotic exoskeletal platform and associated serious games in order to offer information on technological and functional advances that will be included in the device's finalization. In addition, a secondary goal will be to assess the therapeutic effects of a rehabilitation therapy based on the bimanual configuration, comparing it to a unimanual treatment delivered on the same platform (using the specific configuration).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 4, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

January 10, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

April 29, 2022

Status Verified

April 1, 2022

Enrollment Period

8 months

First QC Date

November 10, 2021

Last Update Submit

April 22, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of adverse events and description

    Number and description of adverse events related to the provided intervention

    through the study, an average of 10 months

Secondary Outcomes (18)

  • Changes in EEG-based Interhemispheric coupling index

    Before the intervention, after a 1-hour robotic rehabilitation session

  • Changes in EEG-based Interhemispheric coupling index

    Before the intervention, after a 6-week robotic rehabilitation intervention

  • Changes in EEG-based Interhemispheric coupling index

    Before the intervention, 1 week after the end of the 30-session robotic intervention

  • Changes in EEG-based Connectivity index

    Before the intervention, after a 1-hour robotic rehabilitation session

  • Changes in EEG-based Connectivity index

    Before the intervention, after a 6-week robotic rehabilitation intervention

  • +13 more secondary outcomes

Study Arms (2)

Bimanual group

EXPERIMENTAL

In this group, patients will perform a robotic rehabilitation based on bimanual serious games

Device: Robotic rehabilitation using the Arm Light Exoskeleton Rehab Station (ALEx RS) and bimanual serious games

Unimanual group

ACTIVE COMPARATOR

In this group, patients will perform a robotic rehabilitation based on unimanual serious games

Device: Robotic rehabilitation using the Arm Light Exoskeleton Rehab Station (ALEx RS) and unimanual serious games

Interventions

Patients will undergo a bimanual 30-session robotic rehabilitation, using the robot ALEx RS with the bimanual configuration and the related serious games. Each session will last 45 minute. Daily sessions will be provided, five days a week.

Bimanual group

Patients will undergo a unimanual 30-session robotic rehabilitation, using the robot ALEx RS with the unimanual configuration and the related serious games.Daily sessions will be provided, five days a week.

Unimanual group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • height between 150 and 190 cm;
  • weight not exceeding 130 kg;
  • ischemic injury;
  • first cortical and supra-tentorial event;
  • moderate motor deficit of the upper limb (score on the Fugl-Meyer Assessment - Upper Extremity between 29 and 42);
  • time since stroke event between 1 and 6 months;
  • trunk control test score greater than or equal to 48;
  • healthy bone density and skeleton that does not suffer from unhealed fractures.

You may not qualify if:

  • Relevant medical comorbidities (severe neurological diseases, cardiovascular diseases, diabetes / unstabilized hypertension);
  • Cognitive impairment that prevents understanding of the exercises administered;
  • Unavailability to provide informed consent;
  • Pregnant women;
  • Severe spasticity (Ashworth 4);
  • Major muscle contractures;
  • Excessive asymmetry in the length of the arms;
  • Upper limb prostheses;
  • Excessive joint limitations that make it difficult or painful to use the device;
  • Use of pacemakers or implantation of active devices;
  • Patients who already participate in another clinical study or who are already undergoing another similar robotic rehabilitation treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Don Carlo Gnocchi

Rome, 00168, Italy

RECRUITING

Related Publications (1)

  • Mauro MC, Fasano A, Germanotta M, Cortellini L, Insalaco S, Pavan A, Comanducci A, Guglielmelli E, Aprile IG. Aperiodic brain activity changes in patients with stroke following virtual reality-based upper limb robotic rehabilitation: a pilot Randomized Controlled Trial. Front Hum Neurosci. 2025 Oct 17;19:1671804. doi: 10.3389/fnhum.2025.1671804. eCollection 2025.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Irene Aprile, MD, PhD

    Fondazione Don Carlo Gnocchi Onlus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Irene Aprile, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
CEO

Study Record Dates

First Submitted

November 10, 2021

First Posted

January 4, 2022

Study Start

January 10, 2022

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

April 29, 2022

Record last verified: 2022-04

Locations